Clinical Trial Update: Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating optimized antiplatelet therapy after percutaneous coronary intervention; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Ischemic Heart Disease

Snippet

Sponsor: Shenyang Northern Hospital | Conditions: Ischemic Heart Disease, Acute Coronary Syndromes | Phase 4 | Status: COMPLETED